ArticleDrug design, development and therapy2026
Effect of End-Stage Kidney Disease Factor on the Sedative Effects of Ciprofol.
Dandan Sun, Mingming Han, Xiang Huang, Danjun Lu, Bingqing Zhu, Daoying Zhou, Muzi Hua, Fang Kang, Juan Li
Abstract read
In one paragraphArticle in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Dandan Sun *Department of Anesthesiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People's Republic of China.
Mingming Han *Department of Anesthesiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People's Republic of China.ORCID 0000-0001-5828-9079 Xiang HuangDepartment of Anesthesiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People's Republic of China.
Danjun LuDepartment of Anesthesiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People's Republic of China.
Bingqing ZhuDepartment of Anesthesiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People's Republic of China.
Daoying ZhouDepartment of Anesthesiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310005, People's Republic of China.
Muzi HuaDepartment of Public Health Sciences,University of Connecticut School, Farmington, CT, USA.
Fang KangDepartment of Anesthesiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People's Republic of China.ORCID 0000-0001-8461-8673 Juan LiDepartment of Anesthesiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People's Republic of China.ORCID 0000-0003-0170-0466 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Purpose: To investigate the effect of end-stage kidney disease (ESKD) factor on the sedative effects of ciprofol. Patients and Methods: Elective kidney transplant recipients aged 18-64 years, with a body mass index (BMI) of 18.5-24.0 kg/m Results: No statistically significant difference were observed in the ED Conclusion: ESKD appears to have no significant effect on the sedative efficacy, anesthetic consumption, recovery profile, or safety of ciprofol.
Indexed as
Hypnotics and SedativesKidney Failure, ChronicAdolescentAdultCyclopropanesDose-Response Relationship, DrugFemaleHumansKidney TransplantationMaleMiddle AgedYoung Adult(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenolCyclopropanesHypnotics and Sedativesciprofolend-stage kidney diseasesedative effects
Identifiers
PMID42299330
PMCPMC13265006
What Socratic holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390